Irina Mirzaeva

Dr. Irina Mirzaeva

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Coordination Chemistry Reviews
Verified
Journal Article
Closed access
SKSvetlana Kozlova
Svetlana Kozlova
IMIrina Mirzaeva
Irina Mirzaeva
MRMaxim R. Ryzhikov
Maxim R. Ryzhikov

1 November 2019 in Polyhedron
Verified
Journal Article
Closed access
NRNikolai F. Romashev
Nikolai F. Romashev
Artem GushchinArtem Gushchin
Artem Gushchin
IFIakov Fomenko
Iakov Fomenko
Pavel A. AbramovPavel A. Abramov
Pavel A. Abramov
IMIrina Mirzaeva
Irina Mirzaeva
Maxim N. SokolovMaxim N. Sokolov
Maxim N. Sokolov

Verified
Journal Article
Open access
PDF file
EPEkaterina Pashkina
Ekaterina Pashkina
AAAlina Aktanova
Alina Aktanova
IMIrina Mirzaeva
Irina Mirzaeva
EKEkaterina Kovalenko
Ekaterina Kovalenko
IAIrina Andrienko
Irina Andrienko
VKVladimir Kozlov
Vladimir Kozlov
Cucurbit[7]uril (CB[7]) is a molecular container that may form host–guest complexes with platinum(II) anticancer drugs and modulate their efficacy and safety. In this paper, we report our studies of the effect of CB[7]–oxaliplatin complex and the mixture of CB[7] and carboplatin (1:1) on viability and proliferation of a primary cell culture (peripheral blood mononuclear cells), two tumor cell lines (B16 and K562) and their activity in the animal model of melanoma. At the same time, we studied the impact of platinum (II) drugs with CB[7] on T cells and B cells in vitro. Although the stable CB[7]–carboplatin complex was not formed, the presence of cucurbit[7]uril affected the biological properties of carboplatin. In vivo, CB[7] increased the antitumor effect of carboplatin, but, at the same time, increased its acute toxicity. Compared to free oxaliplatin, its complex with CB[7] shows a greater cytotoxic effect on tumor cell lines B16 and K562, while in vivo, the effects of the free drug and encapsulated drug were comparable. However, in vivo studies also demonstrated that the encapsulation of oxaliplatin in CB[7] lowered the toxicity of the drug.

Verified
Journal Article
Open access
PDF file
NRNikolay Romashev
Nikolay Romashev
IBIvan V. Bakaev
Ivan V. Bakaev
VKVeronika I. Komlyagina
Veronika I. Komlyagina
Pavel A. AbramovPavel A. Abramov
Pavel A. Abramov
IMIrina Mirzaeva
Irina Mirzaeva
Artem GushchinArtem Gushchin
Artem Gushchin
A series of iridium complexes with bis(diisopropylphenyl)iminoacenaphtene (dpp-bian) ligands, [Ir(cod)(dpp-bian)Cl] (1), [Ir(cod)(NO)(dpp-bian)](BF4)2 (2) and [Ir(cod)(dpp-bian)](BF4) (3), were prepared and characterized by spectroscopic techniques, elemental analysis, X-ray diffraction analysis and cyclic voltammetry (CV). The structures of 1–3 feature a square planar backbone consisting of two C = C π-bonds of 1,5-cyclooctadiene (cod) and two nitrogen atoms of dpp-bian supplemented with a chloride ion (for 1) or a NO group (for 2) to complete a square-pyramidal geometry. In the nitrosyl complex 2, the Ir-N-O group has a bent geometry (the angle is 125°). The CV data for 1 and 3 show two reversible waves between 0 and -1.6 V (vs. Ag/AgCl). Reversible oxidation was also found at E1/2 = 0.60 V for 1. Magnetochemical measurements for 2 in a range from 1.77 to 300 K revealed an increase in the magnetic moment with increasing temperature up to 1.2 μB (at 300 K). Nitrosyl complex 2 is unstable in solution and loses its NO group to yield [Ir(cod)(dpp-bian)](BF4) (3). A paramagnetic complex, [Ir(cod)(dpp-bian)](BF4)2 (4), was also detected in the solution of 2 as a result of its decomposition. The EPR spectrum of 4 in CH2Cl2 is described by the spin Hamiltonian Ĥ = gβHŜ with S = 1/2 and gxx = gyy = 2.393 and gzz = 1.88, which are characteristic of the low-spin 5d7-Ir(II) state. DFT calculations were carried out in order to rationalize the experimental results.

1 September 2011 in Inorganica Chimica Acta
Verified
Journal Article
Closed access
PAP.A. Abramov
P.A. Abramov
MSM.N. Sokolov
M.N. Sokolov
EPE.V. Peresypkina
E.V. Peresypkina
IMIrina Mirzaeva
Irina Mirzaeva
NMN.K. Moroz
N.K. Moroz
Vladimir FedinVladimir Fedin
Vladimir Fedin

1 October 2011 in Inorganic Chemistry Communications
Verified
Journal Article
Closed access
MSMaxim N. Sokolov
Maxim N. Sokolov
AAAlexander V. Anyushin
Alexander V. Anyushin
AVAlexander V. Virovets
Alexander V. Virovets
IMIrina Mirzaeva
Irina Mirzaeva
NZNina F. Zakharchuk
Nina F. Zakharchuk
Vladimir FedinVladimir Fedin
Vladimir Fedin